CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Clinical trial NCT03568422 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03568422
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2022-11-21
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.